Skip to search formSkip to main contentSkip to account menu

MAGE-12 peptide vaccine

Known as: MAGE-12 
A synthetic vaccine comprised of a peptide consisting of peptide fragments of melanoma-associated antigen 12 (MAGE-12). MAGE-12 has been identified… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Objective To design and synthesis B-cell epitope of tumor antigen MAGE-12 and investigate its immunogenicity. Methods Based on… 
2007
2007
【Objective】To design and synthesis B-cell eptope of tumor antigen MAGE-12 for the study of immunogen.【Methods】Based on epitope 3… 
2007
2007
Objective:To synthesis and identify B-cell epitope of tumor antigen MAGE-12.Methods:Based on epitope 3~14,a mutiple antigenic… 
2007
2007
Objective To investigate the immunogen effect of a multiple antigenic peptide system(MAP) of a B-cell new epitope of tumor… 
2003
2003
Objective To investigate the expression of MAGE-12 protein in lung cancer and explore the relationship between its expression and… 
2002
2002
Objective To synthesize and identify the antigenic peptide of B cell epitope on tumor antigen MAGE 12. Methods Based on predicted… 
Highly Cited
2001
Highly Cited
2001
The basis of intra‐tumoral and systemic T cell reactivity toward cancer remains unclear. In particular the role that peripheral… 
2001
2001
ObjectiveTo predict the secondary structures, B-cell epitopes and the HLA-A2 restricted cytotoxic T lymphocyte (CTL) epitope of… 
1999
1999
Purpose: The possibility of tumor rejection antigen, encoded by the MAGE-1 gene, being a target for immunotherapy in… 
1996
1996
Melanoma-associated genes (MAGEs) encode tumor-specific antigens that can be recognized by CD8 cytotoxic T lymphocytes. To…